Variant report
Variant | esv2760321 |
---|---|
Chromosome Location | chr13:66196529-66205704 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565956306 | chr13:66199485-66199486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574820615 | chr13:66199508-66199509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76830803 | chr13:66199613-66199614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114557975 | chr13:66199631-66199632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572807078 | chr13:66199647-66199648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147944896 | chr13:66199654-66199655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184190389 | chr13:66199655-66199656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576116428 | chr13:66199670-66199671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530535386 | chr13:66199715-66199716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544255585 | chr13:66199763-66199764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201867366 | chr13:66199823-66199824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76496274 | chr13:66199832-66199833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs398023136 | chr13:66199835-66199836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200659273 | chr13:66199836-66199837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115603066 | chr13:66199849-66199850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530058117 | chr13:66199872-66199873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73496654 | chr13:66199889-66199890 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs186608336 | chr13:66199979-66199980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532474777 | chr13:66199983-66199984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73496655 | chr13:66199996-66199997 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs569289540 | chr13:66200017-66200018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200971501 | chr13:66200027-66200028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs3072990 | chr13:66200029-66200030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397838473 | chr13:66200043-66200044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537825814 | chr13:66200051-66200052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530115046 | chr13:66200115-66200116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554588706 | chr13:66200170-66200171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191976369 | chr13:66200177-66200178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs964666 | chr13:66200191-66200192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554025873 | chr13:66200209-66200210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577389262 | chr13:66200213-66200214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140094699 | chr13:66200229-66200230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560250696 | chr13:66200233-66200234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs964667 | chr13:66200316-66200317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs964668 | chr13:66200362-66200363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575459849 | chr13:66200372-66200373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544218509 | chr13:66200378-66200379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74091294 | chr13:66200379-66200380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182796498 | chr13:66200383-66200384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187117245 | chr13:66200395-66200396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191931005 | chr13:66200396-66200397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532320620 | chr13:66200432-66200433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145516018 | chr13:66200441-66200442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569329225 | chr13:66200456-66200457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531730508 | chr13:66200494-66200495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200744776 | chr13:66200509-66200510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147698703 | chr13:66200531-66200532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182180265 | chr13:66200535-66200536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534194530 | chr13:66200536-66200537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554462665 | chr13:66200653-66200654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66199400-66199600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr13:66199600-66200200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr13:66200200-66200800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr13:66200800-66204800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr13:66204800-66205200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr13:66205200-66205400 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr13:66205200-66205600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr13:66205400-66205600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr13:66205600-66205800 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |